Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reprogramming specific gene expression pathways in B-cell lymphomas.

Ari Melnick1

  • 1Department of Developmental and MolecularBiology, Albert Einstein College of Medicine, Bronx, NewYork 10461, USA. amelnick@aecom.yu.edu

Cell Cycle (Georgetown, Tex.)
|January 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells.

bioRxiv : the preprint server for biology·2026
Same author

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Blood cancer journal·2026
Same author

Author Correction: BCL6 enables Ph<sup>+</sup> acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.

Nature·2026
Same author

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

Research square·2026
Same author

Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9.

The Journal of clinical investigation·2025
Same author

Editorial Expression of Concern: Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

Nature immunology·2025
Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026
Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.

Cell cycle (Georgetown, Tex.)·2026
See all related articles

BCL6, a key repressor in B-cell differentiation, controls cell proliferation and DNA damage responses. Targeting its repression complexes offers a novel transcription therapy for lymphomas and other cancers.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • BCL6 (B-cell lymphoma 6) is a transcriptional repressor crucial for germinal center B-cell differentiation.
  • Germinal center B-cells proliferate rapidly despite DNA damage from recombination and mutation processes.
  • BCL6 downregulation facilitates B-cell exit from the germinal center stage for further differentiation.

Purpose of the Study:

  • To investigate the role of BCL6 in B-cell differentiation and its potential as a therapeutic target.
  • To explore the mechanisms by which BCL6 regulates cell cycle checkpoints and differentiation genes.
  • To propose novel transcription-based therapeutic strategies for BCL6-associated malignancies.

Main Methods:

  • Analysis of BCL6 function during B-cell differentiation.

Related Experiment Videos

  • Investigation of corepressor complex recruitment by BCL6.
  • Examination of gene pathways regulated by BCL6 transcriptional repression.
  • Correlation of BCL6 activity with diffuse large B-cell lymphoma pathogenesis.

    • Main Results:

    • BCL6 mediates biological effects by recruiting corepressors to silence cell cycle and differentiation genes.
    • Distinct transcriptional mechanisms regulate gene pathways targeted by BCL6.
    • BCL6 plays a central role in the pathogenesis of diffuse large B-cell lymphoma.

    Conclusions:

    • Targeting BCL6 transcriptional repression complexes can reprogram B-cells for growth suppression, apoptosis, or differentiation.
    • This approach offers a novel transcription therapy for lymphomas.
    • Potential therapeutic applications may extend to other BCL6-associated tumors.